Communication Bridge 3 Study

Recruiting now · Phase 2

Conditions studied: Primary Progressive Aphasia

In brief

This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.

Key facts

Study ID

NCT06191198

Run by

University of Chicago

People needed

200

Starts

2024-08-23

Expected to finish

2028-07-15

Last updated by the study team

2026-06-01

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• A dementia diagnosis other than Primary Progressive Aphasia
• Participation is co-enrolled in an outside speech language therapy program during the study course.
• Communication partners will be excluded if they have a pre-existing communication impairment that would affect study participation (e.g., aphasia, dementia)
• Medical records will be requested and reviewed to determine eligibility

Where it is running

• University of Chicago - American School Building — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.